Mutual Pharmaceutical Co. v. Bartlett
2013 United States Supreme Court case / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Mutual Pharmaceutical Co. v. Bartlett?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Mutual Pharmaceutical Co. v. Bartlett, 570 U.S. 472 (2013), is a decision by the Supreme Court of the United States holding that generic drug manufactures cannot be held liable under state law for not adequately labeling medication when federal law prohibits them from changing the label from the original brand name drug.[1]
Quick Facts Mutual Pharmaceutical Co. v. Bartlett, Argued March 19, 2013 Decided June 24, 2013 ...
Mutual Pharmaceutical Co. v. Bartlett | |
---|---|
Argued March 19, 2013 Decided June 24, 2013 | |
Full case name | Mutual Pharmaceutical Co. v. Karen L. Bartlett |
Docket no. | 12-142 |
Citations | 570 U.S. 472 (more) 133 S. Ct. 2466; 186 L. Ed. 2d 607; 2013 U.S. LEXIS 4702; 81 U.S.L.W. 4538 |
Argument | Oral argument |
Opinion announcement | Opinion announcement |
Case history | |
Prior | Summary judgment granted in part, Bartlett v. Mutual Pharmaceutical Co., 731 F. Supp. 2d 135 (D.N.H. 2010); motion for new trial denied, 760 F. Supp. 2d 220 (D.N.H. 2011); affirmed, 678 F.3d 30 (1st Cir. 2012); cert. granted, 568 U.S. 1045 (2012). |
Holding | |
Generic drug manufactures cannot be held liable for damages under state law when it conflicts with federal law. | |
Court membership | |
| |
Case opinions | |
Majority | Alito, joined by Roberts, Scalia, Kennedy, Thomas |
Dissent | Breyer, joined by Kagan |
Dissent | Sotomayor, joined by Ginsburg |
Laws applied | |
U.S. Const. Art. VI, Cl. 2 |
Close